Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy

Research output: Contribution to journalPublished meeting abstract


  • M. Groevdal
  • R. Kahn
  • M. Jansson
  • A. Aggerholm
  • P. Antunovic
  • Jan Astermark
  • P. Bernell
  • L. Engstroem
  • L. Kjeldsen
  • O. Linder
  • L. Nilsson
  • A. Olsson
  • M. Skovholm
  • J. Tangen
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cancer and Oncology
Original languageEnglish
Pages (from-to)S49-S50
JournalLeukemia Research
Issue numberSuppl 1
Publication statusPublished - 2009
Publication categoryResearch
Event10th International Symposium on Myelodysplastic Syndromes - Patras, Greece
Duration: 2009 May 62009 May 9